Objective To compare the age distributions and presence of hepatitis B virus (HBV) serological markers between primary hepatic cancer (PHC) patients with and without liver cirrhosis.Methods A total of 547 PHC cases were analyzed retrospectively.After dividing into two groups according to liver cirrhosis status, the between-group differences in age and HBV serological markers, such as hepatitis B e antigen (HBeAg) status, were statistically compared using the Chi-squared test.Results The number of cirrhotic and non-cirrhotic PHC patients was 265 and 282, respectively.HBV infection was present in 221 cirrhotic PHC patients and 256 non-cirrhotic PHC patients (83.4% vs.90.8%) .There was a substantial bias in the proportion of males to females in the cirrhotic PHC patients (7.83∶ 1) .The number of PHC patients<60 years="" old="" was="" similar="" between="" the="" cirrhotic="" and="" non-cirrhotic="" but="" group="" had="" significantly="" more="" patients="">60 years old (P<0.005) .In cirrhotic PHC patients, the HBV infection rate was highest in the <40 years old age group (96.7%) and the HBeAg serological conversion rate was highest in the 40-60 years old age group (89.5%) .In non-cirrhotic PHC patients, the 40-60 years old age group showed the highest HBV infection rate (90.3%) but the lowest HBeAg serological conversion rate (80.0%) .Conclusion PHC with liver cirrhosis mainly occurred in males, with the HBV infection rate being higher in individuals <60 years="" old.non-cirrhotic="" phc="" patients="" were="" more="" often="">60 years old.Many of the HBV-infected PHC patients with cirrhosis had high HBeAg serological conversion rate.
|
[1]Bray F, Ren JS, Masuyer E, et al.Estimates of global cancer prevalencefor 27 sites in the adult population in 2008[OL].[2012-06-03].http://globocan.iarc.fr/factsheet.asp.
|
|
[2]El-Serag HB, Rudolph KL.Hepatocellular carcinoma:Epidemiol-ogy and molecular carcinogenesis[J].Gastroenterolog, 2007, 132 (7) :2557-2576.
|
|
[3]Li CX, Xu GH, Pan HQ, et al.Clinical differences betweenHBeAg-positve and-negative chronic hepatitis B patients over 40-years-old[J].J Clin Hepatol, 2012, 28 (6) :425-427. (inChinese) 李春霞, 徐光华, 潘怀强, 等.40岁以上HBeAg阳性和阴性慢性乙型肝炎病毒感染者的临床特点[J].临床肝胆病杂志, 2012, 28 (6) :425-427.
|
|
[4] Chinese society of hepatology chinese society of infectious diseases.Theguideline of prevention and treatment for chronic hepatitis B (2010 ver-sion) [J].J Clin Hepatol, 2011, 27 (1) :Ⅰ-ⅩⅥ. (in Chinese) 中华医学会肝病学分会, 中华医学会感染病学分会.慢性乙型肝炎防治指南 (2010年版) [J].临床肝胆病杂志, 2011, 27 (1) :Ⅰ-ⅩⅥ.
|
|
[5]郭宏华, 晁阳, 李岩, 等.抗病毒治疗对乙型肝炎相关原发性肝癌临床疗效的影响[J].中国老年学杂志, 2011, 31 (16) :3016-3018.
|
|
[6]Tan YJ.Hepatitis B virus infection and the risk of hepatocellularcarcinoma[J].World J Gastroenterol, 2011, 17 (44) :4853-4857.
|
|
[7]杨芳, 杨春, 苏建家.乙型肝炎的预防和治疗研究进展[J].医学研究杂志, 2011, 40 (4) :12-14.
|
|
[8]Hsu A, Lai CL, Yuen MF.Update on the risk of hepatocellularcarcinoma in chronic hepatitis B virus infection[J].Curr HepatRep, 2011, 10 (2) :106-111.
|
|
[9]Chen YC, Chu CM, Liaw YF.Age-specific prognosis following spon-taneous hepatitis B e antigen seroconversion in chronic hepatitis B[J].Hepatology, 2010, 51 (2) :435-444.
|